| Literature DB >> 33543135 |
Ksenia Musaelyan1,2, Selin Yildizoglu1, James Bozeman1, Andrea Du Preez1,3,4, Martin Egeland1,3,4, Patricia A Zunszain3, Carmine M Pariante3, Cathy Fernandes4,5, Sandrine Thuret1.
Abstract
Adult hippocampal neurogenesis is involved in stress-related disorders such as depression, posttraumatic stress disorders, as well as in the mechanism of antidepressant effects. However, the molecular mechanisms involved in these associations remain to be fully explored. In this study, unpredictable chronic mild stress in mice resulted in a deficit in neuronal dendritic tree development and neuroblast migration in the hippocampal neurogenic niche. To investigate molecular pathways underlying neurogenesis alteration, genome-wide gene expression changes were assessed in the prefrontal cortex, hippocampus and the hypothalamus alongside neurogenesis changes. Cluster analysis showed that the transcriptomic signature of chronic stress is much more prominent in the prefrontal cortex compared to the hippocampus and the hypothalamus. Pathway analyses suggested huntingtin, leptin, myelin regulatory factor, methyl-CpG binding protein and brain-derived neurotrophic factor as the top predicted upstream regulators of transcriptomic changes in the prefrontal cortex. Involvement of the satiety regulating pathways (leptin) was corroborated by behavioural data showing increased food reward motivation in stressed mice. Behavioural and gene expression data also suggested circadian rhythm disruption and activation of circadian clock genes such as Period 2. Interestingly, most of these pathways have been previously shown to be involved in the regulation of adult hippocampal neurogenesis. It is possible that activation of these pathways in the prefrontal cortex by chronic stress indirectly affects neuronal differentiation and migration in the hippocampal neurogenic niche via reciprocal connections between the two brain areas.Entities:
Keywords: adult hippocampal neurogenesis; chronic stress; gene expression; prefrontal cortex
Year: 2020 PMID: 33543135 PMCID: PMC7850288 DOI: 10.1093/braincomms/fcaa153
Source DB: PubMed Journal: Brain Commun ISSN: 2632-1297
Canonical pathways deemed significant in the PFC dataset by IPA
| Ingenuity canonical pathways | −log ( | Ratio |
| Associated differentially expressed genes |
|---|---|---|---|---|
| Axonal guidance signalling | 2.61 | 0.05 | Ephb2, Tuba4a, Gng13, Sema4f, Robo3, Gng7, Tubb2b, Ephb6, Sema6d, Mag, Wnt10a, Efna5, Arhgef6, Lingo1, Mras, Myl4, Fzd5, Sema7a, Adamts4 | |
| Glutamate receptor signalling | 2.12 | 0.10 | Slc17a7, Slc17a6, Homer1, Grm4, Gng7 | |
| Calcium signalling | 2.03 | 0.06 | 2.45 | Camk2a, Tnnc1, Myh3, Rcan3, Myl4, Mef2c, Itpr1, Camkk2, Camk2g |
| Wnt/β-catenin signalling | 2.01 | 0.06 | 0.33 | Csnk2a2, Nlk, Wnt10a, Dkk3, Sox10, Fzd5, Acvr2b, Sox11, Tcf7l2 |
| GABA receptor signalling | 1.94 | 0.09 | Slc32a1, Gabrg1, Gad1, Mras, Ap2s1 | |
| Paxillin signalling | 1.65 | 0.07 | 0.45 | Actn2, Actb, Arhgef6, Mras, Itgb4, Mapk11 |
| Thrombin signalling | 1.64 | 0.05 | 1.89 | Camk2a, Arhgef6, Mras, Myl4, Gng13, Itpr1, Mapk11, Gng7, Camk2g |
| Gαq signalling | 1.63 | 0.06 | 1.13 | Napepld, Adrbk1, Mras, Gng13, Arhgef25, Itpr1, Chrm3, Gng7 |
| Ephrin B signalling | 1.50 | 0.07 | Ephb6, Ephb2, Mras, Gng13, Gng7 | |
| RhoGDI signalling | 1.49 | 0.05 | −0.82 | Dgkz, Arhgdig, Actb, Arhgef6, Mras, Myl4, Gng13, Gng7 |
| B-cell receptor signalling | 1.40 | 0.05 | 2.12 | Synj2, Map3k10, Camk2a, Inpp5f, Mras, Mef2c, Mapk11, Camk2g |
| CCR5 signalling in macrophages | 1.35 | 0.08 | Mras, Gng13, Mapk11, Gng7 | |
| G protein signalling mediated by tubby | 1.34 | 0.09 | Mras, Gng13, Gng7 | |
| Triacylglycerol degradation | 1.33 | 0.14 | Faah, Mgll | |
| α-Adrenergic signalling | 1.31 | 0.06 | Adra2a, Mras, Gng13, Itpr1, Gng7 | |
| Glutamate-dependent acid resistance | 1.30 | 0.50 | GAD1 |
Canonical pathways deemed significant in the PFC dataset ordered by the log (P-value) derived from Fisher’s exact test, with dataset genes/pathway genes ratio and Z-score of predicted pathway up- or downregulation, calculated for pathways where differential gene expression showed consistent direction of change.
Figure 1Behavioural and serological parameters in the UCMS-exposed mice. Male BALB/cAnNCrl mice (n = 10/group) aged 7 weeks at the beginning of the experiment were subjected to UCMS or CNTRL conditions for 6 weeks. (A) Weekly coat state deterioration score measurements from Week 4, *P < 0.05, **P < 0.01 and ***P < 0.001 derived from Mann–Whitney U-test between CNTRL and UCMS, data represent median and interquartile range. (B) Weekly weight monitoring, *P < 0.05 derived from Bonferroni multiple comparison between CNTRL and UCMS group means at Week 1 of UCMS. (C) Sucrose consumption measured once every 2 weeks over 2 consecutive nights, **P < 0.01 derived from Bonferroni multiple comparisons. (D) Time spent grooming during the splash test. (E) Distance moved during a 5-min exposure to a dimly lit open field. (F) Latency to start eating the pellet in the NSF test. (G) Immobility in the PST. (H) Plasma corticosterone (CORT) response to the PST measured 24 h before (PRE-PST) and 30 min after (POST-PST) the test. (I) Plasma levels of the CRP in the blood collected by the cardiac puncture at the end of the behavioural testing battery (7 days after termination of the UCMS protocol). (J) Plasma levels of leptin in the blood collected by the cardiac puncture at the end of the behavioural testing battery (7 days after termination of the UCMS protocol). In D–J, *P < 0.05, **P < 0.01 and ***P < 0.001 derived from two-tailed unpaired t-test, data represent mean ± SEM.
Figure 2Effect of UCMS on the density, morphology and migration of DCX+ neuroblasts and microglial density. (A) Number of neuroblasts residing in the subgranular zone (0) and in 10 different layers of the GZ (0.1–1). (B) Examples of the DCX+ cells with a high relative migration distance in the hippocampal GZ of the UCMS-exposed mice. (C) Average relative migration distance of DCX+ cell bodies. (D) The density of all DCX+ neuroblasts (TOTAL) and of the ‘AB’, ‘CD’ and ‘EF’ types classified based on their dendritic tree morphology. (E) Examples of AB, CD and EF types of neuroblasts. (F) Representative microphotographs of the Iba1+ cells in the DG. (G) Density of the Iba1+ cells in the GZ of the DG. (H) Density of Iba1+ cells in the medial prefrontal cortex (mPFC). (I) Representative microphotographs of Iba1+ cells in the mPFC. Data presented as mean ± SEM, *P < 0.05 and **P < 0.01 derived from unpaired t-test CNTRL versus UCMS; #P < 0.05 derived from post hoc Bonferroni multiple comparisons CNTRL versus UCMS.
Figure 3Heatmap of cluster analysis based on the top 500 variable genes. Adult male BALB/c mice were exposed to UCMS or control (CON) for 4 weeks (n = 8/group) after which fresh frozen brain tissue from selected brain regions [whole HIP, hypothalamus (HYP) and PFC] were subjected to a genome-wide transcriptomic analysis using Illumina microarray platform. The heatmap shows the clustering of samples (top connecting lines) and the heatmap pattern of expression based on intensity values of the top 500 variable genes. The gradient of green and red represents the deviation of each sample intensity value for this gene from the mean intensity across all samples. Individual sample IDs and their groups highlighted at the bottom of the heatmap.
Upstream regulators of differentially expressed genes in the PFC dataset predicted by the IPA software
| Upstream regulator | Gene name | Activation |
| No. of target genes | |
|---|---|---|---|---|---|
| 1 | Htt | Huntingtin | −0.004 | 0.0000 | 25 |
| 2 | Lep | Leptin | −0.970 | 0.0000 | 8 |
| 3 | Myrf | Myelin regulatory factor | 0.0001 | 3 | |
| 4 | Mecp2 | Methyl-CpG binding protein 2 | 1.126 | 0.0001 | 7 |
| 5 | Bdnf | Brain-derived neurotrophic factor | −0.181 | 0.0001 | 9 |
| 6 | Hdac4 | Histone deacetylase 4 | 0.0001 | 8 | |
| 7 | Kmt2a | Lysine methyltransferase 2A | 1.342 | 0.0002 | 5 |
| 8 | Ntrk2 | Neurotrophic receptor tyrosine kinase 2 | 0.0011 | 3 | |
| 9 | Dcc | DCC netrin 1 receptor | 0.0018 | 2 | |
| 10 | Pou4f1 | POU class 4 homeobox 1 | 0.0022 | 4 | |
| 11 | Comt | Catechol- | 0.0035 | 2 | |
| 12 | Mtor | Mechanistic target of rapamycin | 0.0054 | 3 | |
| 13 | Arntl | Aryl hydrocarbon receptor nuclear translocator like | 0.0117 | 2 | |
| 14 | Ascl1 | Achaete-scute family bHLH transcription factor 1 | 0.0123 | 3 | |
| 15 | Bckdk | Branched chain ketoacid dehydrogenase kinase | 0.0153 | 2 |
IPA predicted upstream regulators in the PFC dataset, P-value derived from Fisher’s exact test. Z-score reflects the direction of change where the software was able to make such a prediction.
Figure 4The predicted network of upstream regulators and their target differentially expressed genes in the PFC, designed by the IPA software based on the upstream regulator analysis. Network of upstream regulators linked to genes differentially expressed in the PFC dataset. The relative size of the upstream regulator molecules reflects their significance ranking with Htt, Lep, Myrf, Mecp2 and Bdnf being the top five predicted upstream regulators.
Predicted functions associated with the differentially expressed genes in the PFC dataset
| Categories | Functions annotation |
| Activation | No. of genes |
|---|---|---|---|---|
| Cell-to-cell signalling and interaction | Long-term potentiation of brain | 0.005 | −1.177 | 9 |
| Long-term potentiation of cerebral cortex | 0.007 | −0.923 | 8 | |
| Neurotransmission | 0.009 | −0.164 | 8 | |
| Long-term potentiation | 0.013 | −0.978 | 10 | |
| Release of neurotransmitter | 0.016 | −1.718 | 4 | |
| Synaptic depression | 0.031 | −0.527 | 6 | |
| Cell morphology, cellular assembly and organization, cellular development, cellular function and maintenance, cellular growtd and proliferation, embryonic development, nervous system development and function, tissue development | Branching of neurites | 0.004 | −0.250 | 13 |
| Neuritogenesis | 0.004 | −0.250 | 15 | |
| Dendritic growtd/branching | 0.008 | −1.342 | 11 | |
| Outgrowtd of neurites | 0.050 | 1.898 | 6 | |
| Cellular assembly and organization, cellular development, cellular growtd and proliferation, nervous system development and function, tissue development | Microtubule dynamics | 0.003 | −0.346 | 17 |
| Growtd of neurites | 0.039 | 2.129 | 8 | |
| Cellular development, cellular growtd and proliferation, nervous system development and function, tissue development | Proliferation of neuronal cells | 0.013 | 0.995 | 11 |
| Development of neurons | 0.001 | 0.017 | 20 | |
| Cellular growtd and proliferation | Proliferation of cells | 0.002 | 0.512 | 27 |
| Generation of cells | 0.000 | 0.101 | 22 | |
| Cellular development | Differentiation of cells | 0.001 | 0.460 | 19 |
| Lipid metabolism, molecular transport, small molecule biochemistry | Concentration of lipid | 0.007 | −2.400 | 7 |
| Nervous system development and function, tissue morphology | Density of neurons | 0.014 | −2.213 | 7 |
| Developmental disorder, neurological disease, organismal injury and abnormalities | Cerebral dysgenesis | 0.024 | 0.931 | 4 |
| Behaviour | Behaviour | 0.037 | 0.687 | 8 |
| Cellular movement, nervous system development and function | Migration of neurons | 0.050 | −0.124 | 6 |
Gene functions predicted by IPA software and selected based on their relevance for the brain, number of genes related to each function and the ability of the software to make a prediction regarding the direction of change (activation Z-score).